Heme/Onc Pharm Flashcards

1
Q

Can be used to prevent mast cell degranulation

A

Cromolyn sodium Pharmacology Heme/Onc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Treatment of lead poisoning

A

Dimercaprol and EDTA, succimer in kids Pharmacology Heme/Onc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Heparin (mechanism, use, toxicity)

A

Activates antithrombin, which inactivates thrombin and Xa; used for immediate coagulation and in pregnant women; some patients develop antibodies to platelet factor 4 (HIT) Pharmacology Heme/Onc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Enoxaparin, dalteparin (mechanism, use, toxicity)

A

Same actions as heparin, but has a longer half-life, does not have to be monitored as closely, and has a reduced risk of HIT Pharmacology Heme/Onc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Warfarin (mechanism, use, toxicity)

A

Inactivated gamma-carboxylation of factors II, VII, IX, X, C, and S; used for long-term and non-immediate anticoagulation; can cause tissue necrosis, teratogenic Pharmacology Heme/Onc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Alteplase, reteplase, tenecteplase (mechanism, use, toxicity)

A

Converts plasminogen to plasmin; used as a thrombolytic Pharmacology Heme/Onc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Aspirin (mechanism, use, toxicity)

A

Irreversibly inhibits COX-1 and COX-2; anti-platelet and anti-inflammatory; gastric ulcers, tinnitus, Reye’s syndrome in childhood viral infections Pharmacology Heme/Onc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Clopidogrel, ticlodipine, prasugrel, ticagrelor (mechanism, use, toxicity)

A

Irreversibly blocks ADP receptors on platelets, preventing degranulation; used for acure coronary syndrome; ticlodipine causes neutropenia Pharmacology Heme/Onc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cilostazol, dipyridamole (mechanism, use, toxicity)

A

Phosphodiesterase inhibitor, increases cAMP and decreases ADP, preventing platelet degranulation; nausea, headache, facial flushing, hypotension Pharmacology Heme/Onc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Abciximab, eptifibatide, tirofiban (mechanism, use, toxicity)

A

GPIIb/IIIa inhibitors, preventing platelet aggregation; bleeding, thrombocytopenia Pharmacology Heme/Onc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Methotrexate (mechanism, use, toxicity)

A

Inhibits dihydrofolate reductase, inhibiting DNA synthesis; myelosuppression, macrovesicular fatty change in liver Pharmacology Heme/Onc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

5-fluorouracil (mechanism, use, toxicity)

A

Pyrimidine analog that is activated and inhibits thymidylate synthase, inhibiting DNA synthesis; myelosuppression, photosensitivity Pharmacology Heme/Onc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cytarabine (mechanism, use, toxicity)

A

Pyrimidine analog that inhibits DNA polymerase; leukopenia, thrombocytopenia, megaloblastic anemia Pharmacology Heme/Onc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Azathioprine, 6-mercaptopurine, 6-thioguanine (mechanism, use, toxicity)

A

Purine analogs that are activated by HGPRT and inhibit purine synthesis; toxicity is increased with allopurinol, causes bone marrow, GI, and liver toxicity Pharmacology Heme/Onc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Dactinomycin (actinomycin D) (mechanism, use, toxicity)

A

DNA intercalator; used for childhood tumors; myelosuppression Pharmacology Heme/Onc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Doxorubicin (Adriamycin), daunorubicin (mechanism, use, toxicity)

A

Generates free radicals that cause DNA strand breaks; dilated cardiomyopathy, myelosuppression, alopecia Pharmacology Heme/Onc

16
Q

Bleomycin (mechanism, use, toxicity)

A

Generates free radicals that cause DNA strand breaks; pulmonary fibrosis with minimal myelosuppression Pharmacology Heme/Onc

17
Q

Cyclophosphamide, ifosfamide (mechanism, use, toxicity)

A

Crosslinks DNA (must be activated by liver); myelosuppression, hemhorragic cystitis (can be minimized with mesna) Pharmacology Heme/Onc

18
Q

Carmustine, lomustine, semustine, streptozocin (mechanism, use, toxicity)

A

Used to treat CNS tumors Pharmacology Heme/Onc

19
Q

Busulfan (mechanism, use, toxicity)

A

Alkylates DNA; pulmonary fibrosis, hyperpigmentation Pharmacology Heme/Onc

20
Q

Vincristine, vinblastine (mechanism, use, toxicity)

A

Block microtubule polymerization; vincristine causes neurotoxicity, vinblastine causes bone marro suppression Pharmacology Heme/Onc

21
Q

Paclitaxel (mechanism, use, toxicity)

A

Blocks microtubule breakdown; myelosuppression Pharmacology Heme/Onc

22
Q

Cisplatin, carboplatin (mechanism, use, toxicity)

A

Crosslinks DNA; nephrotoxicity (minimize with chloride diuresis, amifostine), acoustic n. damage Pharmacology Heme/Onc

23
Q

Etoposide, teniposide (mechanism, use, toxicity)

A

Inhibits topoisomerase II; myelosuppression, GI upset, alopecia Pharmacology Heme/Onc

24
Q

Hydroxyurea (mechanism, use, toxicity)

A

Inhibits ribonucleotide reductase; used in cancers and HbSS disease; bone marrow suppression Pharmacology Heme/Onc

25
Q

Prednisone (mechanism, use, toxicity)

A

Unknown but may trigger apoptosis in dividing cells; Cushingoid symptoms Pharmacology Heme/Onc

26
Q

Tamoxifen, raloxifene (mechanism, use, toxicity)

A

Prevents estrogen receptor binding; used in breast cancer and prevention of osteoporosis; tamoxifen increases the risk of endometrial cancer due to agonist effects Pharmacology Heme/Onc

27
Q

Trastuzumab (mechanism, use, toxicity)

A

Antibody against HER-2 receptor; cardiotoxicity Pharmacology Heme/Onc

28
Q

Imatinib (mechanism, use, toxicity)

A

Antibody against bcr-abl tyrosine kinase Pharmacology Heme/Onc

29
Q

Rituximab (mechanism, use, toxicity)

A

Antibody against CD20; used to treat non-Hodgkin’s lymphoma and rheumatoid arthritis Pharmacology Heme/Onc

30
Q

Vemurafenib (mechanism, use, toxicity)

A

B-raf kinase inhibitor (V600 mutation); used in metastatic melanoma Pharmacology Heme/Onc

31
Q

Bevacizumab (mechanism, use, toxicity)

A

Antibody against VEGF Pharmacology Heme/Onc